Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 17,600
+230 (1.32%)
Apr 10, 2026, 3:30 PM KST
Chabiotech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,268,254 | 1,045,049 | 953,951 | 844,583 | 727,476 |
Other Revenue | -0 | -0 | -0 | -0 | - |
| 1,268,254 | 1,045,049 | 953,951 | 844,583 | 727,476 | |
Revenue Growth (YoY) | 21.36% | 9.55% | 12.95% | 16.10% | 9.44% |
Cost of Revenue | 914,057 | 775,225 | 682,936 | 643,558 | 513,978 |
Gross Profit | 354,197 | 269,824 | 271,016 | 201,025 | 213,498 |
Selling, General & Admin | 321,715 | 270,689 | 234,513 | 208,490 | 172,436 |
Research & Development | 24,585 | 15,983 | 14,614 | 14,359 | 13,050 |
Amortization of Goodwill & Intangibles | 1,679 | 2,785 | 2,328 | 2,615 | 1,869 |
Other Operating Expenses | 15,933 | 13,372 | 11,170 | 10,528 | 9,563 |
Operating Expenses | 411,343 | 329,799 | 280,441 | 254,693 | 207,101 |
Operating Income | -57,147 | -59,975 | -9,425 | -53,669 | 6,397 |
Interest Expense | -54,847 | -37,165 | -29,101 | -20,868 | -14,534 |
Interest & Investment Income | 11,462 | 10,442 | 12,923 | 6,593 | 5,177 |
Earnings From Equity Investments | -332.87 | 17,604 | -281.48 | -13,489 | -246.17 |
Currency Exchange Gain (Loss) | -6,087 | 17,805 | 1,529 | 5,442 | 6,934 |
Other Non Operating Income (Expenses) | -15,751 | 28,751 | 23,761 | 11,713 | -14,485 |
EBT Excluding Unusual Items | -122,702 | -22,538 | -594.36 | -64,278 | -10,756 |
Gain (Loss) on Sale of Investments | 542.91 | 263.58 | 3,870 | -6,988 | 1,424 |
Gain (Loss) on Sale of Assets | 29,361 | 21,904 | -26.53 | 138.34 | -657.11 |
Asset Writedown | -41,043 | -1,132 | -453.62 | -329 | 101.17 |
Other Unusual Items | -9,421 | -1,411 | 391.99 | 154.47 | -144.56 |
Pretax Income | -143,263 | -2,914 | 3,188 | -71,302 | -10,033 |
Income Tax Expense | 3,446 | 8,346 | 8,748 | -1,643 | 11,811 |
Earnings From Continuing Operations | -146,708 | -11,260 | -5,560 | -69,659 | -21,844 |
Net Income to Company | -146,708 | -11,260 | -5,560 | -69,659 | -21,844 |
Minority Interest in Earnings | 36,832 | 6,496 | -2,871 | 22,116 | 7,875 |
Net Income | -109,876 | -4,764 | -8,431 | -47,543 | -13,968 |
Net Income to Common | -109,876 | -4,764 | -8,431 | -47,543 | -13,968 |
Shares Outstanding (Basic) | 67 | 32 | 56 | 56 | 55 |
Shares Outstanding (Diluted) | 67 | 32 | 57 | 56 | 55 |
Shares Change (YoY) | 111.35% | -44.35% | 1.43% | 3.24% | 3.82% |
EPS (Basic) | -1637.00 | -150.00 | -149.80 | -844.95 | -256.29 |
EPS (Diluted) | -1637.00 | -150.00 | -149.80 | -845.00 | -256.29 |
Free Cash Flow | -219,089 | -142,191 | -57,346 | -139,754 | -86,350 |
Free Cash Flow Per Share | -3264.11 | -4477.42 | -1004.83 | -2483.78 | -1584.36 |
Gross Margin | 27.93% | 25.82% | 28.41% | 23.80% | 29.35% |
Operating Margin | -4.51% | -5.74% | -0.99% | -6.35% | 0.88% |
Profit Margin | -8.66% | -0.46% | -0.88% | -5.63% | -1.92% |
Free Cash Flow Margin | -17.27% | -13.61% | -6.01% | -16.55% | -11.87% |
EBITDA | -853.71 | -14,966 | 28,374 | -21,149 | 34,260 |
EBITDA Margin | -0.07% | -1.43% | 2.97% | -2.50% | 4.71% |
D&A For EBITDA | 56,293 | 45,009 | 37,799 | 32,520 | 27,862 |
EBIT | -57,147 | -59,975 | -9,425 | -53,669 | 6,397 |
EBIT Margin | -4.51% | -5.74% | -0.99% | -6.35% | 0.88% |
Effective Tax Rate | - | - | 274.41% | - | - |
Advertising Expenses | 6,859 | 11,901 | 9,942 | 9,047 | 8,780 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.